Compare IMRN & ASTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMRN | ASTC |
|---|---|---|
| Founded | 1994 | 1984 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.7M | 10.5M |
| IPO Year | 2016 | 2020 |
| Metric | IMRN | ASTC |
|---|---|---|
| Price | $0.90 | $3.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 13.4K | ★ 17.3K |
| Earning Date | 08-28-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2600.00 |
| EPS | N/A | ★ 0.25 |
| Revenue | N/A | ★ $1,000,000.00 |
| Revenue This Year | $12.00 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $14.32 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.68 | $1.92 |
| 52 Week High | $1.99 | $68.85 |
| Indicator | IMRN | ASTC |
|---|---|---|
| Relative Strength Index (RSI) | 34.56 | 26.15 |
| Support Level | $0.75 | $2.14 |
| Resistance Level | $0.89 | $3.76 |
| Average True Range (ATR) | 0.07 | 0.34 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 22.05 | 7.01 |
Immuron Ltd is a commercial- and clinical-stage biopharmaceutical company focused on the development and commercialization of specifically targeted polyclonal antibodies. Its oral polyclonal antibodies offer delivery within the GI tract and can target viruses or bacteria and neutralize toxins at mucosal surfaces. The Company markets Travelan in Australia, an over-the-counter orally administered passive immunotherapeutic product indicated to reduce the risk of traveler's diarrhea and minor gastrointestinal disorders. Its products include Travelan, ProIBS and Protectyn. Its segments are Research and Development and Hyper-immune products, with Hyper-immune products generating maximum revenue. Australia generates maximum revenue.
Astrotech Corp is a science and technology company. It creates, operates and scales businesses through its subsidiaries and technology platforms, including space-related technology, instrumentation, mass spectrometry, gas chromatography, process-control and environmental analysis technologies. It is evaluating opportunities to identify, develop and commercialize technologies with potential applications in space, defense, industrial, environmental, quantum computing, AI, semiconductor materials, lunar infrastructure and related markets. Its products include Tracer 1000 ETD, tracer 1000 NTD, Labrador HHGC, Fenceline GC, AgLab 1000-D2, among others. It operates in single segment.